Join the 2012 business delegation to BIO

By AusBiotech
Thursday, 01 March, 2012

AusBiotech invites you to take part in the BIO International Convention, the largest global event for the biotechnology industry, attracting the biggest names in biotech, offering key networking and partnering opportunities, and providing insights and inspiration on major trends affecting the industry.

The delegation to BIO, this year to be held on in Boston, is part of AusBiotech’s program of international business missions, to grow and support biotechnology and medical technology in Australia. The most recent mission to BIO in the USA resulted in $524 million in business leads for the participating group.

Exhibition packages on the Australian National Pavilion at BIO are now available. Thousands of companies from around the world and all industry segments will be at BIO global event, ready to build strategic partnerships. More than 15,000 leaders from more than 65 countries attend this gathering. From drug discovery to bio-manufacturing, genomics, biofuels, nanotechnology to cell therapy, BIO covers the wide spectrum of life science innovations and application areas.

The key elements of the event are the education, the networking, the BIO Business Forum partnering and the 1,800 companies showcasing the latest technologies, products and services in the BIO Exhibition.

At BIO, you will meet a full range of executives as more than 65% of attendees have titles of Manager, Director and Executive Management, and come from companies of all sizes with 40% of the attendees from companies of 500+ staff.

The BIO Business Forum and the BIO One-on-One Partnering system makes it easy to find your potential matches and set up face-to-face private meetings.

Participation in the Australian National Pavilion will enable you to meet the right contacts and foster relationships with global decision makers in biotechnology.

For further information, please contact Shevaun Duncan on +61 3 9828 1409 / 0430 383 510.

Related News

TGA rejects Alzheimer's drug due to safety concerns

The TGA determined that the demonstrated efficacy of lecanemab in treating Alzheimer's did...

Defective sperm doubles pre-eclampsia risk in IVF patients

A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...

Free meningococcal B vaccines coming to the NT

The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd